our data suggest that the combination of ciprofloxacin and azlocillin is an effective alternative to ceftazidime and amikacin for the initial empiric therapy of febrile neutropenic patients , is generally well tolerated , and avoids the oto- and nephrotoxicity associated with aminoglycoside use .
C0002499
amikacin
C0002556
aminoglycoside